[Results obtained with Depakine in epilepsy resistant to other therapies. Preliminary note].
D000085:Acetates / Q000008:administration & dosage*; D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D004569:Electroencephalography; D004828:Epilepsies, Partial / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy*; D004832:Epilepsy, Absence / Q000188:drug therapy; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009207:Myoclonus / Q000188:drug therapy; D010634:Phenobarbital / Q000627:therapeutic use
D000085:Acetates; D000927:Anticonvulsants; D010634:Phenobarbital
Sur les résultats obtenus avec le Dépakine dans les épilepsies résistantes aux autres thérapies. Note préliminaire.